Cargando…

Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()

Autosomal Recessive Osteopetrosis is a genetic disorder characterized by increased bone density due to lack of resorption by the osteoclasts. Genetic studies have widely unraveled the molecular basis of the most severe forms, while cases of intermediate severity are more difficult to characterize, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangrazio, Alessandra, Puddu, Alessandro, Oppo, Manuela, Valentini, Maria, Zammataro, Luca, Vellodi, Ashok, Gener, Blanca, Llano-Rivas, Isabel, Raza, Jamal, Atta, Irum, Vezzoni, Paolo, Superti-Furga, Andrea, Villa, Anna, Sobacchi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885796/
https://www.ncbi.nlm.nih.gov/pubmed/24269275
http://dx.doi.org/10.1016/j.bone.2013.11.014
_version_ 1782478827373461504
author Pangrazio, Alessandra
Puddu, Alessandro
Oppo, Manuela
Valentini, Maria
Zammataro, Luca
Vellodi, Ashok
Gener, Blanca
Llano-Rivas, Isabel
Raza, Jamal
Atta, Irum
Vezzoni, Paolo
Superti-Furga, Andrea
Villa, Anna
Sobacchi, Cristina
author_facet Pangrazio, Alessandra
Puddu, Alessandro
Oppo, Manuela
Valentini, Maria
Zammataro, Luca
Vellodi, Ashok
Gener, Blanca
Llano-Rivas, Isabel
Raza, Jamal
Atta, Irum
Vezzoni, Paolo
Superti-Furga, Andrea
Villa, Anna
Sobacchi, Cristina
author_sort Pangrazio, Alessandra
collection PubMed
description Autosomal Recessive Osteopetrosis is a genetic disorder characterized by increased bone density due to lack of resorption by the osteoclasts. Genetic studies have widely unraveled the molecular basis of the most severe forms, while cases of intermediate severity are more difficult to characterize, probably because of a large heterogeneity. Here, we describe the use of exome sequencing in the molecular diagnosis of 2 siblings initially thought to be affected by “intermediate osteopetrosis”, which identified a homozygous mutation in the CTSK gene. Prompted by this finding, we tested by Sanger sequencing 25 additional patients addressed to us for recessive osteopetrosis and found CTSK mutations in 4 of them. In retrospect, their clinical and radiographic features were found to be compatible with, but not typical for, Pycnodysostosis. We sought to identify modifier genes that might have played a role in the clinical manifestation of the disease in these patients, but our results were not informative. In conclusion, we underline the difficulties of differential diagnosis in some patients whose clinical appearance does not fit the classical malignant or benign picture and recommend that CTSK gene be included in the molecular diagnosis of high bone density conditions.
format Online
Article
Text
id pubmed-3885796
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-38857962014-02-01 Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis() Pangrazio, Alessandra Puddu, Alessandro Oppo, Manuela Valentini, Maria Zammataro, Luca Vellodi, Ashok Gener, Blanca Llano-Rivas, Isabel Raza, Jamal Atta, Irum Vezzoni, Paolo Superti-Furga, Andrea Villa, Anna Sobacchi, Cristina Bone Rapid Communication Autosomal Recessive Osteopetrosis is a genetic disorder characterized by increased bone density due to lack of resorption by the osteoclasts. Genetic studies have widely unraveled the molecular basis of the most severe forms, while cases of intermediate severity are more difficult to characterize, probably because of a large heterogeneity. Here, we describe the use of exome sequencing in the molecular diagnosis of 2 siblings initially thought to be affected by “intermediate osteopetrosis”, which identified a homozygous mutation in the CTSK gene. Prompted by this finding, we tested by Sanger sequencing 25 additional patients addressed to us for recessive osteopetrosis and found CTSK mutations in 4 of them. In retrospect, their clinical and radiographic features were found to be compatible with, but not typical for, Pycnodysostosis. We sought to identify modifier genes that might have played a role in the clinical manifestation of the disease in these patients, but our results were not informative. In conclusion, we underline the difficulties of differential diagnosis in some patients whose clinical appearance does not fit the classical malignant or benign picture and recommend that CTSK gene be included in the molecular diagnosis of high bone density conditions. Elsevier Science 2014-02 /pmc/articles/PMC3885796/ /pubmed/24269275 http://dx.doi.org/10.1016/j.bone.2013.11.014 Text en © 2013 The Authors https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the CC BY NC ND license (https://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Rapid Communication
Pangrazio, Alessandra
Puddu, Alessandro
Oppo, Manuela
Valentini, Maria
Zammataro, Luca
Vellodi, Ashok
Gener, Blanca
Llano-Rivas, Isabel
Raza, Jamal
Atta, Irum
Vezzoni, Paolo
Superti-Furga, Andrea
Villa, Anna
Sobacchi, Cristina
Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title_full Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title_fullStr Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title_full_unstemmed Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title_short Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis()
title_sort exome sequencing identifies ctsk mutations in patients originally diagnosed as intermediate osteopetrosis()
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885796/
https://www.ncbi.nlm.nih.gov/pubmed/24269275
http://dx.doi.org/10.1016/j.bone.2013.11.014
work_keys_str_mv AT pangrazioalessandra exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT puddualessandro exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT oppomanuela exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT valentinimaria exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT zammataroluca exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT vellodiashok exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT generblanca exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT llanorivasisabel exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT razajamal exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT attairum exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT vezzonipaolo exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT supertifurgaandrea exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT villaanna exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis
AT sobacchicristina exomesequencingidentifiesctskmutationsinpatientsoriginallydiagnosedasintermediateosteopetrosis